Mode of action of cholecystokinin and related peptides on gallbladder muscle.
D000818:Animals; D001626:Bethanechol Compounds / Q000494:pharmacology; D002108:Ceruletide / Q000494:pharmacology; D002766:Cholecystokinin / Q000494:pharmacology*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D005704:Gallbladder / Q000187:drug effects*; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007700:Kinetics; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D010418:Pentagastrin / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D012601:Scopolamine / Q000494:pharmacology; D013552:Swine; D013779:Tetrodotoxin / Q000494:pharmacology
D001626:Bethanechol Compounds; D010455:Peptides; D013779:Tetrodotoxin; D002108:Ceruletide; D002766:Cholecystokinin; D012601:Scopolamine; D010418:Pentagastrin